Page last updated: 2024-08-21

oxazoles and Hyperlipemia

oxazoles has been researched along with Hyperlipemia in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19904 (30.77)18.7374
1990's2 (15.38)18.2507
2000's6 (46.15)29.6817
2010's1 (7.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CT; Cheng, JT; Cheng, KC; Lin, KC; Niu, CS; Wu, HT1
Aragoncillo, P; Cachofeiro, V; Cediel, E; de las Heras, N; Lahera, V; Oubiña, MP; Sanz-Rosa, D1
Bogdański, P; Bryl, W; Cymerys, M; Kujawska-Łuczak, M; Miczke, A; Pupek-Musialik, D1
Biller, SA; Cap, M; Chandrasena, G; Chang, SY; Chen, S; Cheng, L; Cheng, PT; Devasthale, PV; Doweyko, A; Farrelly, D; Golla, R; Grover, G; Hariharan, N; Harrity, T; Humphreys, WG; Jeon, Y; Ma, Z; Moore, L; Qu, F; Ren, J; Ryono, DE; Sasseville, VG; Seethala, R; Selan, F; Shao, C; Sleph, P; Sun, W; Tieman, A; Wang, W; Wetterau, JR; Zhang, H1
Biller, S; Cap, M; Chen, S; Cheng, PT; Chu, C; Devasthale, P; Farrelly, D; Fenderson, W; Gregg, R; Gu, L; Hariharan, N; Harrity, T; Jeon, Y; Kunselman, L; Mookhtiar, KA; Ponticiello, R; Qu, F; Ren, J; Ryono, D; Seethala, R; Shao, C; Tieman, A; Wang, W; Wetterau, J; Yang, WP; Zhang, H; Zhou, M1
Ernsberger, P; Kossover, R; Previs, SF; Velliquette, RA1
Kajiyama, G; Kawamoto, T; Kubota, S; Maruhashi, A; Nakao, S; Tsunoda, Y; Yamada, K1
Abid, S; Grove, RI; Hartl, KS; Kowala, MC; Mazzucco, CE; Seiler, SM; Warr, GA1
Beucler, I; Dairou, F; Février, B; Scemama, M1
Reid, JL1
Kobayakawa, T; Osuga, K; Yasuda, H1
Blumenbach, L; Kiesselbach, NH; Lehnert, J1
Parkinson, TM; Schultz, JR; Schurr, PE1

Reviews

1 review(s) available for oxazoles and Hyperlipemia

ArticleYear
Rilmenidine: a clinical overview.
    American journal of hypertension, 2000, Volume: 13, Issue:6 Pt 2

    Topics: Albuminuria; Animals; Antihypertensive Agents; Diabetic Angiopathies; Humans; Hyperlipidemias; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Oxazoles; Rilmenidine; Treatment Outcome

2000

Trials

3 trial(s) available for oxazoles and Hyperlipemia

ArticleYear
[The effect of analysed hypotensive drugs on certain metabolic parameters].
    Polskie Archiwum Medycyny Wewnetrznej, 2003, Volume: 109, Issue:3

    Topics: Adult; Antihypertensive Agents; Diabetes Mellitus, Type 2; Felodipine; Female; Humans; Hyperlipidemias; Hypertension; Hyperuricemia; Indoles; Male; Metabolic Syndrome; Middle Aged; Oxazoles; Rilmenidine

2003
[Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
    Annales de cardiologie et d'angeiologie, 1996, Volume: 45, Issue:10

    Topics: Antihypertensive Agents; Captopril; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Lipids; Male; Middle Aged; Oxazoles; Rilmenidine; Time Factors

1996
[Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 3. Results of tolerance tests].
    Arzneimittel-Forschung, 1974, Volume: 24, Issue:0

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Azepines; Blood Glucose; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Diabetes Mellitus; Drug Evaluation; Drug Hypersensitivity; Gastrointestinal Diseases; Humans; Hyperlipidemias; Hypoglycemic Agents; Kidney Diseases; Oxazoles; Paresthesia; Photosensitivity Disorders; Sulfonylurea Compounds; Time Factors

1974

Other Studies

9 other study(ies) available for oxazoles and Hyperlipemia

ArticleYear
A novel mechanism for decreasing plasma lipid level from imidazoline I-1 receptor activation in high fat diet-fed mice.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2011, Volume: 43, Issue:7

    Topics: Animals; Dietary Fats; Feeding Behavior; Gene Expression Regulation; Hep G2 Cells; Humans; Hyperlipidemias; Imidazoline Receptors; Intracellular Signaling Peptides and Proteins; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Oxazoles; Oxidation-Reduction; Receptors, Cytoplasmic and Nuclear; Rilmenidine; Signal Transduction

2011
Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits.
    Clinical science (London, England : 1979), 2003, Volume: 104, Issue:4

    Topics: Acetylcholine; Animals; Aorta; Arteriosclerosis; Bridged Bicyclo Compounds, Heterocyclic; Diet; Endothelium, Vascular; Enzyme Inhibitors; Fibrinolysis; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; In Vitro Techniques; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxazoles; Plasminogen Activator Inhibitor 1; Rabbits; Thromboxane A2; Tissue Plasminogen Activator; Vasoconstrictor Agents

2003
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and
    Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6

    Topics: Adipocytes; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Fatty Acids; Glycine; Humans; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Mice; Mice, Obese; Oxazoles; PPAR alpha; PPAR gamma; Transcriptional Activation; Triglycerides

2005
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Diabetes, 2006, Volume: 55, Issue:1

    Topics: Adiponectin; Animals; Blood Glucose; Corticosterone; Diabetes Mellitus, Type 2; Diet; Female; Glycine; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Liver; Mice; Obesity; Oxazoles; Peroxisome Proliferator-Activated Receptors; Rosiglitazone; Thiazolidinediones

2006
Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.
    Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 372, Issue:4

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Cell Membrane; Cholesterol; Clonidine; Disease Models, Animal; Female; Guanabenz; Hyperlipidemias; Imidazoles; Imidazoline Receptors; Liver; Male; Metabolic Syndrome; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Drug; Rilmenidine; Triglycerides

2006
Effects of ethyl-2-(4-chlorophenyl)-5-ethoxy-4-oxazole acetate (Y-9738) on the serum lipids of patients with hyperlipidemia and/or hypo-HDL-emia.
    Arzneimittel-Forschung, 1984, Volume: 34, Issue:6

    Topics: Adult; Aged; Apolipoproteins A; Aspartate Aminotransferases; Bile; Cholesterol; Cholesterol, HDL; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, HDL; Male; Middle Aged; Oxazoles; Phospholipids; Time Factors; Triglycerides

1984
Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production.
    Arteriosclerosis and thrombosis : a journal of vascular biology, 1993, Volume: 13, Issue:3

    Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Chemotaxis; Cholesterol Esters; Cricetinae; Epoprostenol; Hyperlipidemias; Imidazoles; Macrophages; Male; Membrane Proteins; Monocytes; Oxazoles; Phenoxyacetates; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; Tumor Necrosis Factor-alpha

1993
Experimental hyper-beta-lipoproteinemia and its amelioration by a novel hypolipidemic agent.
    Atherosclerosis, 1978, Volume: 30, Issue:3

    Topics: Animals; Cholesterol; Cholesterol, Dietary; Clofibrate; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Oxazoles; Propylthiouracil; Rats; Triglycerides

1978
Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs.
    Lipids, 1972, Volume: 7, Issue:1

    Topics: Animals; Carboxylic Acids; Cholesterol; Clofibrate; Disease Models, Animal; Fasting; Hyperlipidemias; Hypolipidemic Agents; Injections, Intraperitoneal; Injections, Intravenous; Kinetics; Male; Naphthalenes; Nicotinic Acids; Oxazoles; Phenols; Polysaccharides; Pyrrolidines; Rats; Surface-Active Agents; Thyroxine; Triglycerides; Triparanol

1972